Published in Ann Dermatol Venereol on May 01, 2004
European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol (2009) 3.56
Chronic anal ulceration due to nicorandil. Br J Dermatol (2004) 3.18
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol (2007) 2.85
Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86
Feedback inhibition of immunoglobulin gene rearrangement by membrane mu, but not by secreted mu heavy chains. J Exp Med (1988) 1.78
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J (2000) 1.73
In vitro and in vivo anti-melanoma effects of ciglitazone. J Invest Dermatol (2009) 1.67
Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy (2006) 1.57
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study. Br J Dermatol (2013) 1.50
Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol (2007) 1.44
Morphological features of naevoid melanoma: results of a multicentre study of the International Dermoscopy Society. Br J Dermatol (2015) 1.39
Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells. Oncogene (2011) 1.38
Image quality vs radiation dose of four cone beam computed tomography scanners. Dentomaxillofac Radiol (2008) 1.33
Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest (1991) 1.32
Adherence to topical treatment in psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.26
In vitro analysis of murine B-cell development. Annu Rev Immunol (1985) 1.23
Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 1.22
[Primary essential cutis verticis gyrata: Case report and literature review]. Ann Chir Plast Esthet (2009) 1.21
Clinical variants of the preprotuberant stage of dermatofibrosarcoma protuberans. Br J Dermatol (2005) 1.19
Cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol (2010) 1.13
A classification of psoriasis vulgaris according to phenotype. Br J Dermatol (2007) 1.13
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.13
What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.10
Chronic urticaria: an internet survey of health behaviours, symptom patterns and treatment needs in European adult patients. Br J Dermatol (2008) 1.06
Aeromonas hydrophila with plasmid-borne class A extended-spectrum β-lactamase TEM-24 and three chromosomal class B, C, and D β-lactamases, isolated from a patient with necrotizing fasciitis. Antimicrob Agents Chemother (2004) 1.05
Methotrexate in psoriasis: a systematic review of treatment modalities, incidence, risk factors and monitoring of liver toxicity. J Eur Acad Dermatol Venereol (2011) 1.04
Defective barrier function in melasma skin. J Eur Acad Dermatol Venereol (2011) 1.02
Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 1.02
Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension. Br J Dermatol (2012) 1.01
Assessment of risk of psoriatic arthritis in patients with plaque psoriasis: a systematic review of the literature. J Eur Acad Dermatol Venereol (2010) 1.00
Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies. J Eur Acad Dermatol Venereol (2013) 0.99
Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial. Br J Dermatol (2009) 0.99
Treatment of erosive oral lichen planus by the 308 nm excimer laser. Lasers Surg Med (2004) 0.99
Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1). Br J Dermatol (2011) 0.99
Guidelines for clinical trials in melasma. Pigmentation Disorders Academy. Br J Dermatol (2006) 0.98
Aplasia cutis congenita with dystrophic epidermolysis bullosa: clinical and mutational study. Br J Dermatol (2014) 0.96
Biological therapies in the systemic management of psoriasis: International Consensus Conference. Br J Dermatol (2004) 0.95
SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Oncogene (2011) 0.93
Ciglitazone negatively regulates CXCL1 signaling through MITF to suppress melanoma growth. Cell Death Differ (2010) 0.92
Divided nevus of the penis: an unusual location. Arch Dermatol (1998) 0.92
Chronic urticaria: a patient survey on quality-of-life, treatment usage and doctor-patient relation. Allergy (2009) 0.89
Efficacy and safety of oral retinoids in different psoriasis subtypes: a systematic literature review. J Eur Acad Dermatol Venereol (2011) 0.88
Improvements in patient-reported outcomes in moderate-to-severe psoriasis patients receiving continuous or paused etanercept treatment over 54 weeks: the CRYSTEL study. J Eur Acad Dermatol Venereol (2009) 0.88
Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol Venereol (2011) 0.87
Management of field change in actinic keratosis. Br J Dermatol (2007) 0.86
Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial. Br J Dermatol (2006) 0.86
A randomized, controlled study of the safety and efficacy of topical corticosteroid treatments of sunburn in healthy volunteers. Clin Exp Dermatol (2002) 0.85
Iatrogenic kwashiorkor developing after bypass surgery. Clin Exp Dermatol (2013) 0.85
[Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema]. Ann Dermatol Venereol (2009) 0.85
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensus. J Eur Acad Dermatol Venereol (2006) 0.84
Evidence-based recommendations on topical treatment and phototherapy of psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol (2012) 0.84
Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy. J Dermatolog Treat (2003) 0.84
[Myiasis caused by Dermatoba hominis after an organized tours in Amazonia]. Presse Med (2000) 0.84
[595 nm pulse dye laser therapy for viral warts: a single-blind randomized comparative study versus placebo]. Ann Dermatol Venereol (2007) 0.84
Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion. J Eur Acad Dermatol Venereol (2013) 0.83
Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol (2011) 0.83
Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J Eur Acad Dermatol Venereol (2014) 0.83
Machining and accuracy studies for a tibial knee implant using a force-controlled robot. Comput Aided Surg (1998) 0.83
Efficacy of psoralen UV-A therapy vs. narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2012) 0.82
Evidence-based recommendations on the role of dermatologists in the diagnosis and management of psoriatic arthritis: systematic review and expert opinion. J Eur Acad Dermatol Venereol (2014) 0.81
[Melanoma within naevus spilus: 5 cases]. Ann Dermatol Venereol (2006) 0.81
Adalimumab for moderate to severe chronic plaque psoriasis: efficacy and safety of retreatment and disease recurrence following withdrawal from therapy. Br J Dermatol (2011) 0.81
308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. Br J Dermatol (2010) 0.81
Imatinib mesilate (Glivec): a systemic depigmenting agent for extensive vitiligo? Br J Dermatol (2005) 0.81
Alcohol consumption and psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol (2013) 0.80
[Mycobacterium fortuitum skin infection occurring after a facelift]. Ann Dermatol Venereol (2004) 0.80
Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage. Br J Dermatol (2010) 0.80
Expression of immunoglobulin genes in transgenic mice and transfected cells. Ann N Y Acad Sci (1988) 0.80
A phase II dose-ranging study of topical resiquimod to treat actinic keratosis. Br J Dermatol (2008) 0.80
Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review. J Eur Acad Dermatol Venereol (2012) 0.79
Evidence-based recommendations to assess psoriasis severity: systematic literature review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol (2010) 0.79
Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis. Int J Dermatol (2004) 0.79
Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations. Br J Dermatol (2011) 0.79
Symptoms dermatologists should look for in daily practice to improve detection of psoriatic arthritis in psoriasis patients: an expert group consensus. J Eur Acad Dermatol Venereol (2014) 0.79
Histopathological characterization of primary cutaneous melanoma using infrared microimaging: a proof-of-concept study. Br J Dermatol (2010) 0.78
Late-onset skin fragility in childhood: a case of junctional epidermolysis bullosa of late onset caused by a missense mutation in COL17A1. Br J Dermatol (2013) 0.77
[Bupropion (Zyban) induced urticaria: 2 cases]. Ann Dermatol Venereol (2003) 0.77
[Treatment of mycosis fungoides by 308 nm excimer laser: a clinical and histological study in 10 patients]. Ann Dermatol Venereol (2007) 0.76
Treatment for palmoplantar pustular psoriasis: systematic literature review, evidence-based recommendations and expert opinion. J Eur Acad Dermatol Venereol (2014) 0.76
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial. Br J Dermatol (2005) 0.76
Altered tissue expression pattern of cell adhesion molecules, ICAM-1, E-selectin and VCAM-1, in bullous pemphigoid during methotrexate therapy. Exp Dermatol (2004) 0.76
Use of conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists. J Eur Acad Dermatol Venereol (2011) 0.76
Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses. Curr Med Res Opin (2007) 0.75
Use of high-definition optical coherent tomography (HD-OCT) for imaging of melanoma. Br J Dermatol (2013) 0.75
Infectious and toxic cellulitis due to suicide attempt by subcutaneous injection of ricin. Br J Dermatol (2004) 0.75
How to prescribe antihistamines for chronic idiopathic urticaria: desloratadine daily vs PRN and quality of life. Allergy (2008) 0.75
[A guide for education programs in atopic dermatitis]. Ann Dermatol Venereol (2007) 0.75